Hegg, Roberto; Carvalho, J.; Graziani, S.; Valduga, C. J.; Fernandes, D. C.; Azevedo, C. H. M.; Lopes, A. C.; Rodrigues, D. G.; Maranhão, Raul Cavalcante 
Source: American Society of Clinical Oncology. Conference titles: Annual Meeting of the American Society of Clinical Oncology. Unidades: FM, FCF
Assunto: LIPOPROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HEGG, Roberto et al. Use of cholesterol-rich microemulsion that binds to low-density lipotein (LDL) receptors as avehicle for etoposide. American Society of Clinical Oncology. Chicago: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 16 nov. 2024. , 2003APA
Hegg, R., Carvalho, J., Graziani, S., Valduga, C. J., Fernandes, D. C., Azevedo, C. H. M., et al. (2003). Use of cholesterol-rich microemulsion that binds to low-density lipotein (LDL) receptors as avehicle for etoposide. American Society of Clinical Oncology. Chicago: Faculdade de Medicina, Universidade de São Paulo.NLM
Hegg R, Carvalho J, Graziani S, Valduga CJ, Fernandes DC, Azevedo CHM, Lopes AC, Rodrigues DG, Maranhão RC. Use of cholesterol-rich microemulsion that binds to low-density lipotein (LDL) receptors as avehicle for etoposide. American Society of Clinical Oncology. 2003 ; 22 146.[citado 2024 nov. 16 ]Vancouver
Hegg R, Carvalho J, Graziani S, Valduga CJ, Fernandes DC, Azevedo CHM, Lopes AC, Rodrigues DG, Maranhão RC. Use of cholesterol-rich microemulsion that binds to low-density lipotein (LDL) receptors as avehicle for etoposide. American Society of Clinical Oncology. 2003 ; 22 146.[citado 2024 nov. 16 ]
